OrbiMed Advisors Lowers Stake in Intercept Pharma (ICPT) to 7.00%
Tweet Send to a Friend
In an amended 13D filing on Intercept Pharma (NASDAQ: ICPT), hedge fund OrbiMed Advisors disclosed a 7.00%, or 1,485,324 share ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
